leadf
logo-loader
viewHorizon Discovery Group PLC

Horizon Discovery Group inks 'significant' reference standards deal

Chris Claxton, Vice President of Investor Relations and Corporate Communications at Horizon Discovery Group PLC (LON:HZD) talks to Proactive about the company entering into an agreement with an unnamed global molecular diagnostics provider to develop reference standards for non-invasive prenatal testing (NIPT).

Quick facts: Horizon Discovery Group PLC

Price: 191 GBX

AIM:HZD
Market: AIM
Market Cap: £302.26 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Horizon Discovery Group PLC named herein, including the promotion by the Company of Horizon Discovery Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Acquisition gives Horizon Discovery a 'full and complete suite of tools' to...

Chris Claxton, VP Investor Relations & Corporate Communications at Horizon Discovery Group PLC (LON:HZD), discusses with Proactive their 'transformational' acquisition of GE healthcare business Dharmacon. The US$85mln deal was announced in July and funded through cash and shares and...

on 4/9/17

2 min read